BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2017
View Archived Issues
Moleculin Biotech reports discovery of follow-on to WP-1122
Read More
Takeda initiates phase II study of TAK-935 in developmental or epileptic encephalopathies
Read More
FDA's ODAC to evaluate Zepsyre's potential for pediatric cancers
Read More
ISU Abxis is enrolling patients in phase I trial of ISU-304
Read More
UCB details development of PI3Kdelta inhibitor seletalisib
Read More
Patient recruitment begins in phase I trial of LXI-15029 in patients with advanced solid tumors
Read More
Phase I data presented for M-3814 in patients with solid tumors
Read More
Reata Pharmaceuticals granted FDA orphan drug designation for omaveloxolone
Read More
Angion Biomedica enters license agreement with ElexoPharm
Read More
Zogenix 's ZX-008 wins FDA orphan drug designation
Read More
PharmNovo prepares delta opioid receptor agonist PN-6047 for clinical investigation
Read More
Kamada withdraws MAA for inhaled AAT therapy
Read More
Zealand Pharma and Beta Bionics report phase IIa data on dasiglucagon with artificial pancreas
Read More
U.K.'s MHRA gives positive opinion to idebenone through EAMS for DMD
Read More
Pirotinib tested in phase I study in advanced solid tumor patients
Read More
Amgen develops PET probe for cytotoxic lymphocyte detection for cancer immunotherapy
Read More
DelMar Pharmaceuticals cleared to conduct phase III study of VAL-083 in GBM
Read More
Ewopharma acquires rights to several Eisai products
Read More
Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors
Read More
AstraZeneca/Cancer Research Technology patent GLS inhibitors
Read More
FDA approves subcutaneous Haegarda to prevent HAE attacks
Read More
GlaxoSmithKline presents novel UDP-3-O-acyl-GlcNAc deacetylase inhibitors
Read More
Sarepta Therapeutics and Genethon sign gene therapy research collaboration for DMD
Read More
FDA issues complete response letter for Trintellix
Read More
FDA grants orphan drug designation to IMO-2125 for melanoma
Read More
SM-04690 shows promise in phase II trial for knee osteoarthritis
Read More
FDA approves Tafinlar + Mekinist for BRAF V600E-positive NSCLC
Read More
CPI-444 demonstrates clinical activity in patients with NSCLC and RCC
Read More